Table 2 Biochemical parameters of the study population at baseline and after 28 days of the active phase of VLCKD
Parameters (N = 12) | Baseline | Day 28 of VLCKD | p-value | Δ % |
|---|---|---|---|---|
Fasting plasma glucose (mg/dL) | 88.82 ± 7.95 | 80.64 ± 8.76 | 0.084 | − 8.15 ± 15.73 |
Insulin (μU/mL) | 12.48 ± 6.68 | 9.88 ± 6.60 | 0.218 | − 16.70 ± 47.24 |
HoMA− IR | 2.71 ± 1.50 | 2.09 ± 1.55 | 0.248 | − 17.93 ± 55.15 |
Total cholesterol (mg/dL) | 184.73 ± 26.01 | 147.55 ± 30.62 | 0.002 | − 19.41 ± 15.19 |
HDL cholesterol (mg/dL) | 61.22 ± 11.37 | 53.04 ± 13.86 | 0.002 | − 14.02 ± 12.23 |
LDL cholesterol (mg/dL) | 103.38 ± 24.50 | 77.13 ± 20.05 | 0.003 | − 23.16 ± 18.82 |
Triglycerides (mg/dL) | 102.36 ± 57.58 | 82.82 ± 32.12 | 0.223 | − 7.77 ± 32.07 |
Azotemia (mg/dL) | 32.00 ± 9.38 | 28.50 ± 9.95 | 0.158 | − 9.33 ± 21.96 |
Creatinemia (mg/dL) | 0.76 ± 0.17 | 0.75 ± 0.12 | 0.777 | 0.59 ± 14.50 |
Uricemia (mg/dL) | 4.93 ± 0.92 | 5.39 ± 1.13 | 0.197 | 10.58 ± 22.13 |
AST (U/L) | 25.50 ± 10.82 | 24.17 ± 10.67 | 0.258 | − 3.80 ± 15.68 |
ALT (U/L) | 29.67 ± 19.13 | 25.58 ± 18.34 | 0.055 | − 11.68 ± 21.10 |
γGT (U/L) | 15.92 ± 4.72 | 13.92 ± 4.25 | 0.074 | − 10.60 ± 21.48 |
ESR (mm/h) | 28.44 ± 15.21 | 22.44 ± 18.25 | 0.307 | − 18.30 ± 47.46 |
Sodiemia (mmol/L) | 4.30 ± 0.27 | 4.33 ± 0.37 | 0.591 | 0.31 ± 1.89 |
Potassiema (mmol/L) | 4.30 ± 0.27 | 4.33 ± 0–37 | 0.700 | 0.44 ± 4.49 |